Long-Release Tacrolimus Wins FDA Nod
(MedPage Today) -- An extended-release formulation of tacrolimus (Astagraf XL) for preventing kidney transplant rejection has been approved by the FDA, its manufacturer said.
Source: MedPage Today Primary Care - Category: Primary Care Source Type: news
More News: Kidney Transplant | Kidney Transplantation | Primary Care | Prograf | Tacrolimus | Transplant Surgery | Transplants | Urology & Nephrology